Xiaofang Pharmaceutical (603207.SH) plans to launch a restricted stock incentive plan in 2026.

Wisdom Financial APP News, Xiaofang Pharmaceuticals (603207.SH) disclosed the 2026 Restricted Stock Incentive Plan (draft), the total number of restricted stocks proposed to be granted in the incentive plan shall not exceed 1.6 million shares, accounting for 1% of the total share capital of the company at the time of the announcement of the incentive plan draft. Among them, no more than 1.28 million shares will be granted for the first time, with 0.32 million shares reserved. The grant price for the first grant of restricted stocks is RMB 11.91 per share. The number of recipients of the first grant of incentive stocks shall not exceed 158.